5UZK image
Deposition Date 2017-02-26
Release Date 2018-03-07
Last Version Date 2024-11-20
Entry Detail
PDB ID:
5UZK
Title:
Crystal Structure of PKA bound to an pyrrolo pyridine inhibitor
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.25
R-Value Work:
0.18
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:cAMP-dependent protein kinase catalytic subunit alpha
Gene (Uniprot):PRKACA
Chain IDs:A
Chain Length:351
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:cAMP-dependent protein kinase inhibitor alpha
Gene (Uniprot):PKIA
Chain IDs:B (auth: I)
Chain Length:18
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP A SER modified residue
TPO A THR modified residue
Ligand Molecules
Primary Citation
ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitors.
Bioorg. Med. Chem. Lett. 28 2622 2626 (2018)
PMID: 30082069 DOI: 10.1016/j.bmcl.2018.06.040

Abstact

Rho kinase (ROCK) inhibitors are potential therapeutic agents for the treatment of a variety of disorders including hypertension, glaucoma and erectile dysfunction. Here we disclose a series of potent and selective ROCK inhibitors based on a substituted 7-azaindole scaffold. Substitution of the 3-position of 7-azaindole led to compounds such as 37, which possess excellent ROCK inhibitory potency and high selectivity against the closely related kinase PKA.

Legend

Protein

Chemical

Disease

Primary Citation of related structures